Programme at a glance

Programme at a glance, London

Thursday, 26 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
17.45 - 18.45
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: Jean‑Yves Reginster, John A. Kanis
17.45
Best clinical papers published in 2020
René Rizzoli
18.30
Opening of the meeting
Cyrus Cooper
18.35
Presentation of the 2020 ESCEO Medal of Excellence
18.40
Presentation of the IOF Olof Johnell Science Award
Friday, 27 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
09.00 - 10.30
SCIENTIFIC SESSION I
Chairpersons: Cyrus Cooper, Jean‑Yves Reginster
09.00
Plenary Lecture 1
Management of musculoskeletal disease from cradle to grave Cyrus Cooper
09.30
Oral communication selected from abstracts
10.30 - 12.10
SCIENTIFIC SESSION II
Chairpersons: John A. Kanis, René Rizzoli
10.30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10.35
Presentation of the IOF President's Award
10.40
Plenary Lecture 2
Building bone strength with anabolic agents Michael R. McClung
11.10
Oral communication selected from abstracts
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Transgender medicine, bone and muscle
Jean‑Marc Kaufman
Impact of glucocorticoids on bone and muscle
Evelien Gielen
HIV and bone
Emmanuel Biver
Is screening of osteoporosis useful?
E. M. Curtis
14.00 - 15.00
Poster Viewing Session I
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
Educational Lecture
Dietary patterns and fracture risk Stefania Maggi
14.00 - 15.00
ESCEO Symposium
‣ Determinants of the differences between the ESCEO and OARSI 2019 guidelines for the management of knee osteoarthritis
Chairpersons: Ali Mobasheri, Jean‑Yves Reginster
Similarities and differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis Tim McAlindon
How can we explain the differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis? Nigel K. Arden
Discussion (Leader: Olivier Bruyère) All
14.00 - 15.00
Update of the ESCEO recommendations for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia
Chairpersons: Charlotte Beaudart, Roger A. Fielding
Introduction Alfonso Cruz Jentoft
Patients to be included in clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia Mario Miguel Rosa
Primary and secondary endpoints for clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia Andrea Laslop
Discussion (Leader : Andrea Trombetti): All participants of the Working Group
Conclusion Jürgen Bauer
15.00 - 17.00
SCIENTIFIC SESSION III
Chairpersons: Radmila Matijevic, Manju Chandran
15.00
Plenary Lecture 3
Management of bone disease in cancer Robert E. Coleman
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 4
Thyroid, bone and cartilage G Williams
15.00 - 16.45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
15.45
Presentation of the IOF Committee of National Societies Medal
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Saturday, 28 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESCEO-IOF Working Group
‣ Role of orthopaedic surgeons to ensure optimal Vitamin D levels in patients operated for an osteoporotic fracture
Chairpersons: Didier Hannouche, Gerrit Maier
Introduction and scope of the problem René Rizzoli
Prevalence of Vitamin D sufficiency/deficiency in patients admitted to the orthopaedic ward Nicholas Harvey
Benefits of Vitamin D in patients with fragility fracture Kyriakos Papavasiliou
Supplementation with Vitamin D during rehabilitation Giovanni Iolascon
Discussion (Leader: Maria Luisa Brandi): All participants of the Working Group
Closure of the meeting
09.00 - 10.30
SCIENTIFIC SESSION IV
Chairpersons: Evelien Gielen, Bess Dawson‑Hughes
09.00
Plenary Lecture 5
Bone and cartilage talk together Ali Mobasheri
09.30
Oral communication selected from abstracts
10.20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10.30 - 12.10
SCIENTIFIC SESSION V
Chairpersons: Elaine M. Dennison, Maria Luisa Brandi
10.30
Presentation of the IOF Medal of Achievement
10.40
Plenary Lecture 6
Are there treatments for sarcopenia? Marjolein Visser
11.10
Oral communication selected from abstracts
12.15 - 13.45
AVAILABLE INDUSTRY SATELLITE LUNCH SYMPOSIUM
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Calcium-vitamin D, still a role in osteoporosis management?
Elaine M. Dennison
Discussion of complex bone disorder cases
Nicholas R. Fuggle
Fracture during childhood and adolescence

Rehabilitation after fragility fracture
Olivier Bruyère
14.00 - 15.00
Poster Viewing Session II
14.00 - 15.10
Oral presentation of selected posters
14.00 - 15.00
Educational Lecture
Peak bone mass and primary fracture prevention Peter R. Ebeling
15.00 - 17.00
SCIENTIFIC SESSION VI
Chairpersons: Charlotte Beaudart, Claudia Campusano
15.00
Plenary Lecture 7
Gut microbiome, bone and joint G Schett
15.30
Oral communication selected from abstracts
16.30
Plenary Lecture 8
Rehabilitation of menopausal hormone therapy in osteoporosis management I Lambrinoudaki
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
17.00 - 18.30
AVAILABLE INDUSTRY SATELLITE SYMPOSIUM
Sunday, 29 August 2021
01.00 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
NON-SPONSORED SYMPOSIA
08.00 - 09.00
AVAILABLE INDUSTRY BREAKFAST SYMPOSIUM
08.00 - 09.00
ESCEO-IOF-SICOT joint Symposium : Fracture Liaison Services (FLS) in Orthopaedic Surgery
Chairpersons: Josée Delisle, Philippe Halbout
Opening message Philippe Halbout, Josée Delisle
Success story of collaboration between orthopaedics and rest of the world in FLS! How can I work with my orthopaedic surgeon? Julio Fernandes
Getting FLSs sustainable- key steps Kassim Javaid
Teams and empowerment! How to create synergy between the Nurse, Doctor, Family and the Patient? Josée Delisle
Crossfire and Q&A
Closing message Josée Delisle
09.00 - 10.00
MEET-THE-EXPERT SESSIONS
Can we influence fracture repair?
Julio Fernandes
FLS and fracture risk reduction
Kassim Javaid
How to warrant reliable data for calciotropic hormones and bone turnover markers assays
Etienne Cavalier
Management of men with osteoporosis
Alberto Ferlin
09.00 - 10.00
Poster Viewing Session III
10.00 - 12.00
SCIENTIFIC SESSION VII
Chairpersons: Stefania Maggi, Gemma Adib
10.00
Plenary Lecture 9
Is genetics helping to improve osteoporosis management ? E Duncan
10.30
Presentation of the ESCEO-IOF Young Investigator Awards
10.40
Oral communication selected from abstracts
11.40
Plenary Lecture 10
New approaches of rare skeletal diseases management Maria Luisa Brandi
12.00 - 13.00
NON-SPONSORED SYMPOSIA